메뉴 건너뛰기




Volumn 7, Issue 10, 2012, Pages

Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLIN H; DNA BINDING PROTEIN; DOCETAXEL; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 6; GEMCITABINE; MMS19 PROTEIN; NAVELBINE; PACLITAXEL; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE M1; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

EID: 84868268419     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048350     Document Type: Article
Times cited : (31)

References (28)
  • 1
    • 80051580618 scopus 로고    scopus 로고
    • Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
    • Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
    • (2011) CA Cancer J Clin , vol.61 , pp. 212-236
    • Siegel, R.1    Ward, E.2    Brawley, O.3    Jemal, A.4
  • 2
    • 0037050352 scopus 로고    scopus 로고
    • Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
    • Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98.
    • (2002) N Engl J Med , vol.346 , pp. 92-98
    • Schiller, J.H.1    Harrington, D.2    Belani, C.P.3    Langer, C.4    Sandler, A.5
  • 3
    • 49049089802 scopus 로고    scopus 로고
    • Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
    • Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, et al. (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26: 3543-3551.
    • (2008) J Clin Oncol , vol.26 , pp. 3543-3551
    • Scagliotti, G.V.1    Parikh, P.2    von Pawel, J.3    Biesma, B.4    Vansteenkiste, J.5
  • 4
    • 0042413836 scopus 로고    scopus 로고
    • Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group
    • Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, et al. (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21: 3016-3024.
    • (2003) J Clin Oncol , vol.21 , pp. 3016-3024
    • Fossella, F.1    Pereira, J.R.2    von Pawel, J.3    Pluzanska, A.4    Gorbounova, V.5
  • 6
    • 53749097825 scopus 로고    scopus 로고
    • Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials
    • NSCLC Meta-Analyses Collaborative Group
    • NSCLC Meta-Analyses Collaborative Group (2008) Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 26: 4617-4625.
    • (2008) J Clin Oncol , vol.26 , pp. 4617-4625
  • 7
    • 0029963622 scopus 로고    scopus 로고
    • Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer
    • Nebert DW, McKinnon RA, Puga A, (1996) Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15: 273-280.
    • (1996) DNA Cell Biol , vol.15 , pp. 273-280
    • Nebert, D.W.1    McKinnon, R.A.2    Puga, A.3
  • 8
    • 79551543927 scopus 로고    scopus 로고
    • UV-induced photolesions elicit ATR-kinase-dependent signaling in non-cycling cells through nucleotide excision repair-dependent and -independent pathways
    • Vrouwe MG, Pines A, Overmeer RM, Hanada K, Mullenders LH, (2011) UV-induced photolesions elicit ATR-kinase-dependent signaling in non-cycling cells through nucleotide excision repair-dependent and-independent pathways. J Cell Sci 124: 435-446.
    • (2011) J Cell Sci , vol.124 , pp. 435-446
    • Vrouwe, M.G.1    Pines, A.2    Overmeer, R.M.3    Hanada, K.4    Mullenders, L.H.5
  • 9
    • 33745951429 scopus 로고    scopus 로고
    • Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer
    • Bernig T, Chanock SJ, (2006) Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn 6: 319-331.
    • (2006) Expert Rev Mol Diagn , vol.6 , pp. 319-331
    • Bernig, T.1    Chanock, S.J.2
  • 10
    • 34249812370 scopus 로고    scopus 로고
    • Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer
    • Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, et al. (2007) Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res 13: 2876-2881.
    • (2007) Clin Cancer Res , vol.13 , pp. 2876-2881
    • Giachino, D.F.1    Ghio, P.2    Regazzoni, S.3    Mandrile, G.4    Novello, S.5
  • 11
    • 66649120041 scopus 로고    scopus 로고
    • Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population
    • Wu W, Zhang W, Qiao R, Chen D, Wang H, et al. (2009) Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population. Clin Cancer Res 15: 3889-3895.
    • (2009) Clin Cancer Res , vol.15 , pp. 3889-3895
    • Wu, W.1    Zhang, W.2    Qiao, R.3    Chen, D.4    Wang, H.5
  • 12
    • 77649238161 scopus 로고    scopus 로고
    • Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients
    • Chen S, Huo X, Lin Y, Ban H, Lin Y, et al. (2010) Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients. Int J Hyg Environ Health 213: 140-145.
    • (2010) Int J Hyg Environ Health , vol.213 , pp. 140-145
    • Chen, S.1    Huo, X.2    Lin, Y.3    Ban, H.4    Lin, Y.5
  • 14
    • 0345256652 scopus 로고    scopus 로고
    • Cisplatin: mode of cytotoxic action and molecular basis of resistance
    • Siddik ZH, (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
    • (2003) Oncogene , vol.22 , pp. 7265-7279
    • Siddik, Z.H.1
  • 15
    • 0034688940 scopus 로고    scopus 로고
    • DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy
    • van de Vaart PJ, Belderbos J, de Jong D, Sneeuw KC, Majoor D, et al. (2000) DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy. Int J Cancer 89: 160-166.
    • (2000) Int J Cancer , vol.89 , pp. 160-166
    • van de Vaart, P.J.1    Belderbos, J.2    de Jong, D.3    Sneeuw, K.C.4    Majoor, D.5
  • 16
    • 0036270993 scopus 로고    scopus 로고
    • DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
    • Bernstein C, Bernstein H, Payne CM, Garewal H, (2002) DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511: 145-178.
    • (2002) Mutat Res , vol.511 , pp. 145-178
    • Bernstein, C.1    Bernstein, H.2    Payne, C.M.3    Garewal, H.4
  • 17
    • 4344567395 scopus 로고    scopus 로고
    • XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
    • Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, et al. (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22: 2594-2601.
    • (2004) J Clin Oncol , vol.22 , pp. 2594-2601
    • Gurubhagavatula, S.1    Liu, G.2    Park, S.3    Zhou, W.4    Su, L.5
  • 18
    • 20044368468 scopus 로고    scopus 로고
    • Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
    • Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, et al. (2005) Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res 11: 1534-1538.
    • (2005) Clin Cancer Res , vol.11 , pp. 1534-1538
    • Suk, R.1    Gurubhagavatula, S.2    Park, S.3    Zhou, W.4    Su, L.5
  • 19
    • 33646241783 scopus 로고    scopus 로고
    • Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer
    • Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, et al. (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12: 2101-2108.
    • (2006) Clin Cancer Res , vol.12 , pp. 2101-2108
    • Moreno, V.1    Gemignani, F.2    Landi, S.3    Gioia-Patricola, L.4    Chabrier, A.5
  • 20
    • 33644870366 scopus 로고    scopus 로고
    • Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
    • Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27: 560-567.
    • (2006) Carcinogenesis , vol.27 , pp. 560-567
    • Zienolddiny, S.1    Campa, D.2    Lind, H.3    Ryberg, D.4    Skaug, V.5
  • 21
    • 38149140159 scopus 로고    scopus 로고
    • A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer
    • Lin Z, Zhang X, Tuo J, Guo Y, Green B, et al. (2008) A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer. Hum Mutat 29: 113-122.
    • (2008) Hum Mutat , vol.29 , pp. 113-122
    • Lin, Z.1    Zhang, X.2    Tuo, J.3    Guo, Y.4    Green, B.5
  • 22
    • 33746360586 scopus 로고    scopus 로고
    • Identification of MMS19 domains with distinct functions in NER and transcription
    • Hatfield MD, Reis AM, Obeso D, Cook JR, Thompson DM, et al. (2006) Identification of MMS19 domains with distinct functions in NER and transcription. DNA Repair (Amst) 5: 914-924.
    • (2006) DNA Repair (Amst) , vol.5 , pp. 914-924
    • Hatfield, M.D.1    Reis, A.M.2    Obeso, D.3    Cook, J.R.4    Thompson, D.M.5
  • 23
    • 0027994603 scopus 로고
    • A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
    • Fisher RP, Morgan DO, (1994) A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713-724.
    • (1994) Cell , vol.78 , pp. 713-724
    • Fisher, R.P.1    Morgan, D.O.2
  • 24
    • 80053617155 scopus 로고    scopus 로고
    • The role of XPC: implications in cancer and oxidative DNA damage
    • Melis JP, Luijten M, Mullenders LH, van Steeg H, (2011) The role of XPC: implications in cancer and oxidative DNA damage. Mutat Res 728: 107-117.
    • (2011) Mutat Res , vol.728 , pp. 107-117
    • Melis, J.P.1    Luijten, M.2    Mullenders, L.H.3    van Steeg, H.4
  • 25
    • 33750579074 scopus 로고    scopus 로고
    • RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer
    • Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, et al. (2006) RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. J Clin Oncol 24: 4731-4737.
    • (2006) J Clin Oncol , vol.24 , pp. 4731-4737
    • Bepler, G.1    Kusmartseva, I.2    Sharma, S.3    Gautam, A.4    Cantor, A.5
  • 26
    • 78149286935 scopus 로고    scopus 로고
    • Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer
    • Sakano S, Hinoda Y, Sasaki M, Wada T, Matsumoto H, et al. (2010) Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer. Pharmacogenomics 11: 1377-1387.
    • (2010) Pharmacogenomics , vol.11 , pp. 1377-1387
    • Sakano, S.1    Hinoda, Y.2    Sasaki, M.3    Wada, T.4    Matsumoto, H.5
  • 27
    • 67650627436 scopus 로고    scopus 로고
    • Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array
    • Kweekel DM, Antonini NF, Nortier JW, Punt CJ, Gelderblom H, et al. (2009) Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. Br J Cancer 101: 357-362.
    • (2009) Br J Cancer , vol.101 , pp. 357-362
    • Kweekel, D.M.1    Antonini, N.F.2    Nortier, J.W.3    Punt, C.J.4    Gelderblom, H.5
  • 28
    • 52149093686 scopus 로고    scopus 로고
    • XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population
    • Wang Z, Xu B, Lin D, Tan W, Leaw S, et al. (2008) XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer 62: 99-104.
    • (2008) Lung Cancer , vol.62 , pp. 99-104
    • Wang, Z.1    Xu, B.2    Lin, D.3    Tan, W.4    Leaw, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.